We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants

Delisted

SGYPW was delisted on the 6th of December, 2016.

0 hedge funds and large institutions have $0 invested in Synergy Pharmaceuticals, Inc. - Warrants in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more call options, than puts

Call options by funds: $6.18M | Put options by funds: $2.97M

100% less funds holding

Funds holding: 30 (-3)

100% less capital invested

Capital invested by funds: $289K → $0 (-$289K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
Holders Change
-3
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
3
Calls
$6.18M
Puts
$2.97M
Net Calls
+$3.21M
Net Calls Change
+$922K

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
-$124K -348,743 Closed
Twin Tree Management
2
Twin Tree Management
Texas
-$21K -29,429 Closed

SGYPW Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q4 2016, worth a combined $0 — down 100% from $289K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SGYPW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $124K sold.

  • 0 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q4 2016, down from 3 in Q3 2016.
  • Funds reported $0 of Synergy Pharmaceuticals, Inc. - Warrants stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q4 2016 and 3 closed out, a net change of -3 holders.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q4 2016 was Sabby Management, an estimated $124K sold.

Based on aggregated 13F filings for Q4 2016.